COVID-19 Services and Products

The impact that the COVID-19 pandemic has had worldwide is of unprecedented proportions, with over 280 million infected and 5.4 million deaths in 224 countries and areas.

From diagnostics to drug discovery and vaccine development, GenScript has developed a comprehensive range of products and services that scientists can use to accelerate COVID-19/SARS-CoV-2 research and development.

*Data current as of 27/12/2021

Services and Products

SARS-CoV-2 qRT-PCR Detection Assay

  • GenScript receives CE marking for SARS-CoV-2 qPCR assay.
  • RUO assays target ORF1ab, RdRP, N and E genes in SARS-CoV-2 genome.
  • Customized primers and probes for all four genes.

Plasmids for SARS-CoV-2 Detection
and Research In-stock

Pseudovirus Particles

  • Pseudovirus particles serve as a safer alternative to conventional approaches. We offer different pseudovirus packaging options from a wide range of SARS-CoV-2 vectors and bioluminescent tags.

Peptides and Peptide Library

  • A series of SARS-CoV-2 Peptide Libraries based on GenScript's rich experience in peptide design and synthesis. These SARS-CoV-2 Peptide Libraries can be used for T-cell assays, Immune monitoring, Antigen specific T-cell stimulation, T-cell expansion and Cellular immune response.

Discoveries on SARS-CoV-2 from Our Customers

Since the outbreak of COVID-19 pandemic, the scientists over the world have been dedicated to studying the underlying molecular mechanism of SARS-CoV-2 infection. They constructed SARS-CoV-2 plasmid clone which can be used to evaluate the antivirals activities of functional protein materials and furtherly as key reagent for the coronavirus study (i.e., anti-virus antibody detection). Some papers reported the structure of SARS-CoV-2 proteins especially spike protein, helping researchers develop efficient detection assay approaches.

To date, over 97 publications on SARS-CoV-2 have cited and acknowledged GenScript for high quality services and products provided to accelerate the coronavirus research covering diagnostic detection reagents development, SAR-CoV-2 vaccine and therapeutics discovery. We are proud to help the global scientific community from 100+ laboratories in 12 countries, and the human population by making research easy with our sophisticated technologies.

Connect with MolecularCloud for the latest information on SARS-CoV-2.


WHO Guidance

On 17 January 2020, WHO provided interim guidance to laboratories and stakeholders involved in laboratory testing of patients who meet suspected case of pneumonia associated with the 2019 novel coronavirus.

Available Protocols

Diagnostic detection of Wuhan coronavirus 2019 by real-time RT-PCR – Charité, Berlin Germany (pdf)

Detection of 2019 novel coronavirus (2019-nCoV) in suspected human cases by RT-PCR – Hong Kong University (pdf)

China CDC Primers and probes for detection 2019-nCoV

SARS-CoV-2 qRT-PCR detection assay-1 step-1 plex Manual (pdf)

GenScript COVID-19 detection tech notes (pdf)

Join Us in the Discussion

What can the scientific community do to fight the COVID-19? Share your thoughts with other researchers to win a $100 coupon or a free hoodie!


Do you like the current new website?